Jane Street
TEVA icon

Jane Street’s Teva Pharmaceuticals TEVA Stock Holding History

Jane Street’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.22M Sell
183,647
-1,280,991
-87% -$42.7M ﹤0.01% 3412
2026
Q1 		$44.1M Sell
1,464,638
-154,241
-10% -$4.96M 0.01% 1147
2025
Q4 		$50.5M Sell
1,618,879
-1,384,754
-46% -$34.1M 0.01% 938
2025
Q3 		$60.7M Buy
3,003,633
+163,386
+6% +$2.87M 0.01% 852
2025
Q2 		$47.6M Buy
2,840,247
+833,926
+42% +$13.5M 0.01% 793
2025
Q1 		$30.8M Buy
2,006,321
+1,673,872
+503% +$29.9M 0.01% 975
2024
Q4 		$7.33M Buy
332,449
+218,467
+192% +$3.97M ﹤0.01% 2198
2024
Q3 		$2.05M Sell
113,982
-1,094,188
-91% -$19.2M ﹤0.01% 4416
2024
Q2 		$19.6M Buy
1,208,170
+466,371
+63% +$7.18M ﹤0.01% 1334
2024
Q1 		$10.5M Sell
741,799
-64,351
-8% -$811K ﹤0.01% 1766
2023
Q4 		$8.42M Sell
806,150
-1,452,310
-64% -$13.6M ﹤0.01% 2161
2023
Q3 		$23M Sell
2,258,460
-3,948,528
-64% -$36.8M 0.01% 996
2023
Q2 		$46.7M Buy
6,206,988
+3,138,239
+102% +$25.4M 0.02% 625
2023
Q1 		$27.2M Buy
3,068,749
+652,768
+27% +$6.45M 0.01% 810
2022
Q4 		$22M Sell
2,415,981
-699,837
-22% -$6.11M 0.01% 942
2022
Q3 		$25.1M Sell
3,115,818
-2,619,664
-46% -$23.2M 0.01% 892
2022
Q2 		$43.1M Buy
5,735,482
+660,665
+13% +$5.76M 0.02% 621
2022
Q1 		$47.7M Sell
5,074,817
-781,126
-13% -$6.52M 0.02% 701
2021
Q4 		$46.9M Buy
5,855,943
+1,423,606
+32% +$12.8M 0.02% 682
2021
Q3 		$43.2M Buy
4,432,337
+2,607,362
+143% +$24.4M 0.02% 667
2021
Q2 		$18.1M Sell
1,824,975
-363,073
-17% -$3.84M 0.01% 1158
2021
Q1 		$25.3M Buy
2,188,048
+443,825
+25% +$5.09M 0.01% 805
2020
Q4 		$16.8M Buy
1,744,223
+810,051
+87% +$7.76M 0.01% 988
2020
Q3 		$8.42M Buy
934,172
+355,086
+61% +$3.76M 0.01% 1360
2020
Q2 		$7.14M Sell
579,086
-5,463,515
-90% -$61.8M 0.01% 1461
2020
Q1 		$54.3M Buy
6,042,601
+5,255,315
+668% +$53.8M 0.05% 236
2019
Q4 		$7.71M Sell
787,286
-2,927,625
-79% -$26.1M 0.01% 786
2019
Q3 		$25.6M Buy
3,714,911
+376,825
+11% +$2.89M 0.04% 297
2019
Q2 		$30.8M Buy
3,338,086
+1,851,435
+125% +$22.3M 0.05% 260
2019
Q1 		$23.3M Sell
1,486,651
-309,085
-17% -$5.45M 0.04% 373
2018
Q4 		$27.7M Buy
1,795,736
+1,585,664
+755% +$32.5M 0.06% 233
2018
Q3 		$4.53M Buy
210,072
+37,997
+22% +$882K 0.01% 1119
2018
Q2 		$4.18M Buy
172,075
+83,563
+94% +$1.7M 0.01% 1206
2018
Q1 		$1.51M Sell
88,512
-102,644
-54% -$2M ﹤0.01% 2181
2017
Q4 		$3.62M Sell
191,156
-2,163,620
-92% -$32.5M 0.01% 1082
2017
Q3 		$41.4M Buy
2,354,776
+1,832,264
+351% +$41.2M 0.13% 146
2017
Q2 		$17.4M Buy
522,512
+497,823
+2,016% +$15.4M 0.06% 275
2017
Q1 		$792K Sell
24,689
-61,859
-71% -$2.11M ﹤0.01% 2352
2016
Q4 		$3.14M Buy
86,548
+72,382
+511% +$2.89M 0.01% 968
2016
Q3 		$652K Sell
14,166
-530,916
-97% -$27.7M ﹤0.01% 2470
2016
Q2 		$27.4M Sell
545,082
-208,174
-28% -$11.1M 0.14% 132
2016
Q1 		$40.3M Buy
753,256
+715,188
+1,879% +$42M 0.23% 84
2015
Q4 		$2.5M Buy
+38,068
New +$2.35M 0.02% 888
2015
Q3 		– Sell
-70,448
Closed -$4.57M – 4135
2015
Q2 		$4.16M Sell
70,448
-872,007
-93% -$53.8M 0.03% 563
2015
Q1 		$58.7M Buy
942,455
+901,086
+2,178% +$52.4M 0.45% 33
2014
Q4 		$2.38M Sell
41,369
-120,815
-74% -$6.73M 0.02% 587
2014
Q3 		$8.72M Buy
162,184
+145,319
+862% +$7.7M 0.09% 190
2014
Q2 		$884K Sell
16,865
-375,298
-96% -$19.2M 0.01% 989
2014
Q1 		$20.7M Buy
392,163
+384,902
+5,301% +$17.8M 0.23% 65
2013
Q4 		$291K Buy
+7,261
New +$286K ﹤0.01% 1677

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's TEVA Position: Q2 2026 in Review

Jane Street reduced its Teva Pharmaceuticals (TEVA) stake by 87% in Q2 2026, selling an estimated $42.7M and leaving 183,647 shares worth $6.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3412.

Jane Street first reported a position in TEVA in Q4 2013 and has held it in 50 quarters since. The position peaked at $60.7M in Q3 2025. 639 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Jane Street held 183,647 shares of Teva Pharmaceuticals worth $6.22M as of Q2 2026.
  • Jane Street sold 1,280,991 Teva Pharmaceuticals shares in Q2 2026, an estimated $42.7M.
  • Teva Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3412 holding.
  • Jane Street first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
  • Jane Street's Teva Pharmaceuticals position peaked at $60.7M in Q3 2025.
  • 639 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.